Organon & Co - Company Profile
Powered by 
All the data and insights you need on Organon & Co in one report.
$295
- Save hours of research time and resources with
our up-to-date Organon & Co Strategy Report
- Understand Organon & Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Organon & Co (Organon) develops and commercializes drugs for the treatment of women's health, heart disease, dermatology, allergies, and asthma.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Organon conducts R&D to develop its product candidates using its technical expertise to pursue new indications, new formulations, and new regions. The company identifies scientific collaborations and acquisitions to develop early and late-stage assets and enhance its pipeline. The company also concentrates on developing medicines like HLX11 for treating HER2+ breast cancer and OG-6219 for treating endometriosis. It is investigating ebopiprant (OBE022) with ObsEva for the treatment of preterm labor; and FOR-6219 for the treatment of polycystic ovarian syndrome (PCOS). It focuses on internal scientific expertise and collaborations with partners, and advanced product development opportunities, data generation, product registration, and licensing globally. In FY2022, the company spent US$471 million on R&D, which as a percentage of revenue stood at 7.6%.
Product Categories
Overview
Areas of treatment include immunology, oncology, ophthalmology, diabetes, and neuroscience. Distributes its products in 20 countries. Product portfolio includes Renflexis, Brenzys Aybintio, Hadlima, Ontruzant.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Disease areas includes cardiovascular, dermatology, respiratory, and non-opioid pain management. Distributes its products in more than 140 countries and territories. Product portfolio includes Zetia, Singular, Propecia, Hyzaar, and Atozet.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes manufacturing sales to Merck and third parties.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes contraception and fertility drugs. Product portfolio includes Nexplanon, NuvaRing, Follistim AQ Catridge, and Elonva.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
- Asia Pacific and Japan
- China
- Europe and Canada
- Latin America, Middle East, Russia and Africa
- Other
- United States
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer